John Aballi
President and CEO at Exagen Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2023
3 years of board service in total across 1 board, counting each seat separately. Longest: Exagen Inc., 3 years.
Exagen Inc.
Director · President and CEO
Chief executive roles
Exagen Inc.
· President and CEO
Dates unknown
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| May 16, 2024 | Exagen Inc. | Open-market purchase | +40,401 | $1.92 | $77,570 |
| Feb 29, 2024 | Exagen Inc. | Grant or award | +9,804 | $1.91 | $18,726 |
| Feb 20, 2024 | Exagen Inc. | Grant or award | +175,000 | — | — |
| Oct 17, 2023 | Exagen Inc. | Open-market sale | −33,819 | $1.75 | $59,183 |
| Aug 31, 2023 | Exagen Inc. | Grant or award | +9,803 | $2.14 | $20,978 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.